心室辅助装置新进展  

Advance in ventricular assist devices and current controversies

作　　者：肖学钧[1] 黄焕雷[1] 

机构地区：[1]广东省心血管病研究所广东省医学科学院广东省结构性心脏病重点实验室广东省人民医院心外科,广州510100

出　　处：《中华胸心血管外科杂志》2017年第10期632-634,共3页Chinese Journal of Thoracic and Cardiovascular Surgery

摘　　要：心脏移植是治疗严重心力衰竭的主要手段,患者术后生存率和生活质量均有提高.由于供体短缺,心脏移植手术量无明显增加.左心辅助装置可用于心脏移植过渡、终点治疗以及心肌恢复治疗.对于老年患者,左心辅助装置常可替代心脏移植.本文对心室辅助装置治疗心力衰竭效果、争论问题及展望作一综述.Advanced heart failure（AHF）is a global epidemic with high morbidity and mortality.Heart transplantation has been the main method for the treatment of AHF.However, for the extreme shortage of organ donations, heart transplanta-tion is no obvious increase.Left ventricular assist devices（LVADs）have become a viable therapeutic approach as a bridge to heart transplantation, as well as destination therapy or part of the bridge to recovery.This review focuses on the therapeutic effect with VAD, current controversies and prospects.

关 键 词：心室辅助装置 心脏移植过渡 严重心力衰竭 左心辅助装置 恢复治疗 老年患者 术后生存率 供体短缺 

分 类 号：R654.2[医药卫生—外科学]